市場調査レポート

商品コード

DNase、リガーゼ、RNAポリメラーゼの世界市場：規模、シェア、動向分析レポート（DNaseアプリケーション別、リガーゼアプリケーション別、RNAポリメラーゼアプリケーション別、地域別展望と予測、2024-2031年）

Global DNases, Ligases, and RNA Polymerases Market Size, Share & Trends Analysis Report By DNases Application, By Ligases Application (Oligonucleotide Synthesis and Others), By RNA Polymerases Application, By Regional Outlook and Forecast, 2024 - 2031

出版日: 2024年06月14日
発行: KBV Research
ページ情報: 英文 215 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 3,600 534,780円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能で、回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 4,320 641,736円

レポートPDFを同一企業内の10名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能で、回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Corporate User License)

USD 6,048 898,430円

レポートPDFを同一企業のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能で、回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.55円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

DNase、リガーゼ、RNAポリメラーゼ市場規模は、予測期間中に10.4%のCAGRで市場成長し、2031年までに16億米ドルに達すると予想されています。

KBVカーディナルマトリックスで提示された分析に基づくと、サーモフィッシャーサイエンティフィック社は、DNase、リガーゼ、RNAポリメラーゼ市場の先駆者です。2022年2月、サーモフィッシャーサイエンティフィック社は、メッセンジャーRNAを開発しているバイオテクノロジー企業であるモダナ社と提携しました。このコラボレーションの下、両社は、モダナ社のCOVID-19ワクチンであるSpikevax、およびその他の治験中のmRNA薬を米国でそのチャネルで確実に大規模に製造することを目指しました。メルクKGaA、アジレントテクノロジーズ社、キアゲンNVなどの企業は、DNase、リガーゼ、RNAポリメラーゼ市場の主要なイノベーターの一部です。

COVID-19の影響分析

パンデミックの初期段階では、世界のサプライチェーン、物流、製造業務の混乱により、DNase、リガーゼ、RNAポリメラーゼ、その他の分子生物学試薬の入手性に影響が出ました。国境閉鎖、渡航制限、ロックダウン措置により商品の移動が妨げられ、製品の出荷と配送が遅れました。COVID-19パンデミックは、学術機関、バイオテクノロジー企業、製薬会社の研究開発活動を混乱させ、実験のタイムラインとプロジェクトの進行に影響を与えました。したがって、 COVID-19パンデミックの影響は市場に中程度の影響を及ぼしました。

市場成長要因

ゲノム調査には、DNAとRNA配列の研究が含まれ、遺伝的変異、遺伝子発現パターン、および生物学的プロセスの根底にある分子メカニズムを理解します。DNase、リガーゼ、RNAポリメラーゼは、シーケンシング、PCR増幅、クローニング、および遺伝子発現分析などの核酸操作技術で使用される重要な酵素であり、市場の需要を促進します。したがって、ゲノム調査の拡大が市場の成長を促進しています。

バイオテクノロジーおよび製薬業界は、バイオ医薬品開発のさまざまな用途で、DNase、リガーゼ、RNAポリメラーゼに大きく依存しています。これらの酵素は、分子クローニング、遺伝子発現、タンパク質生産、および治療用タンパク質、モノクローナル抗体、遺伝子治療などの生物製剤生産で使用される組み換えDNA技術に不可欠です。したがって、バイオテクノロジーおよび製薬業界は市場の成長を推進しています。

市場抑制要因

酵素生産には、発酵、精製、配合などの複雑な製造プロセスが伴い、特殊な装置、設備、専門知識が必要です。これらのプロセスはリソース集約型であり、インフラストラクチャ、テクノロジー、熟練した人材への多額の投資が必要であり、生産コストが高くなります。したがって、酵素生産コストの高さが市場の成長を牽引しています。

DNasesの用途別展望

DNasesの用途に基づいて、市場はバイオ医薬品処理とその他に分かれています。その他セグメントは、2023年に市場で23％の収益シェアを記録しました。DNasesは、土壌や水中のDNA汚染物質を分解するために環境バイオテクノロジーで利用され、汚染された環境のバイオレメディエーションに役立ちます。DNasesは、乳製品や肉などの食品からDNAを除去し、腐敗を防ぎ、保存期間を延ばすために食品業界でも使用されています。

リガーゼの応用別展望

リガーゼの用途に基づいて、市場はオリゴヌクレオチド合成とその他に分類されます。2023年には、その他のセグメントが市場で56％の収益シェアを獲得しました。リガーゼは、分子クローニングおよびサブクローニング手順中にベクターなどのDNA断片を結合し、DNAを挿入します。オリゴヌクレオチド断片をより長いDNA配列に連結することにより、合成遺伝子の組み立てを容易にします。

RNAポリメラーゼの応用別展望

RNAポリメラーゼの用途別に、市場はmRNA生産とその他に分かれています。その他セグメントは、2023年に市場で顕著な収益シェアを獲得しました。RNAポリメラーゼは、IVT反応で使用され、in vitroでDNAテンプレートからRNA転写産物を生成します。これらの合成RNA分子は、分子生物学調査における貴重なツールとして機能し、さまざまな用途のRNAプローブ、標準、コントロール、および発現ベクターの生成を可能にします。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカにわたって分析されています。2023年には、アジア太平洋地域が市場で28％の大きな収益シェアを生み出しました。アジア太平洋地域は、遺伝的変異、疾患メカニズム、集団遺伝学を理解するための大規模なゲノム調査イニシアチブの本拠地です。DNase、リガーゼ、RNAポリメラーゼは、DNA配列決定、遺伝子発現解析、ゲノム編集などのゲノム調査で重要な役割を果たしており、地域全体の学術機関や調査機関で酵素製品の需要を促進しています。

北米
- 北米の市場：国別
  - 米国
  - カナダ
  - メキシコ
  - その他北米地域
欧州
- 欧州の市場：国別
  - ドイツ
  - 英国
  - フランス
  - ロシア
  - スペイン
  - イタリア
  - その他欧州地域
アジア太平洋地域
- アジア太平洋の市場：国別
  - 中国
  - 日本
  - インド
  - 韓国
  - シンガポール
  - マレーシア
  - その他アジア太平洋地域
ラテンアメリカ・中東・アフリカ
- ラテンアメリカ・中東・アフリカの市場：国別
  - ブラジル
  - アルゼンチン
  - アラブ首長国連邦
  - サウジアラビア
  - 南アフリカ
  - ナイジェリア
  - その他ラテンアメリカ・中東・アフリカ地域

第9章企業プロファイル

Thermo Fisher Scientific, Inc
Merck KGaA
Agilent Technologies, Inc
Promega Corporation
RayBiotech Life, Inc
Qiagen NV
Abnova Corporation
Takara Bio Inc（Takara Holdings Inc.）
BPS Bioscience, Inc
New England Biolabs, Inc

第10章 DNase、リガーゼ、RNAポリメラーゼ市場の成功必須条件

図表

LIST OF TABLES

TABLE 1 Global DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 2 Global DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- DNases, Ligases, And RNA Polymerases Market
TABLE 4 Product Launches And Product Expansions- DNases, Ligases, And RNA Polymerases Market
TABLE 5 Acquisition and Mergers- DNases, Ligases, And RNA Polymerases Market
TABLE 6 Geographical Expansions- DNases, Ligases, And RNA Polymerases Market
TABLE 7 Global DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 8 Global DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 9 Global Biopharmaceutical Processing Market by Region, 2020 - 2023, USD Million
TABLE 10 Global Biopharmaceutical Processing Market by Region, 2024 - 2031, USD Million
TABLE 11 Global Others Market by Region, 2020 - 2023, USD Million
TABLE 12 Global Others Market by Region, 2024 - 2031, USD Million
TABLE 13 Global DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 14 Global DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 15 Global Oligonucleotide Synthesis Market by Region, 2020 - 2023, USD Million
TABLE 16 Global Oligonucleotide Synthesis Market by Region, 2024 - 2031, USD Million
TABLE 17 Global Others Market by Region, 2020 - 2023, USD Million
TABLE 18 Global Others Market by Region, 2024 - 2031, USD Million
TABLE 19 Global DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 20 Global DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 21 Global mRNA Production Market by Region, 2020 - 2023, USD Million
TABLE 22 Global mRNA Production Market by Region, 2024 - 2031, USD Million
TABLE 23 Global Others Market by Region, 2020 - 2023, USD Million
TABLE 24 Global Others Market by Region, 2024 - 2031, USD Million
TABLE 25 Global DNases, Ligases, And RNA Polymerases Market by Region, 2020 - 2023, USD Million
TABLE 26 Global DNases, Ligases, And RNA Polymerases Market by Region, 2024 - 2031, USD Million
TABLE 27 North America DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 28 North America DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 29 North America DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 30 North America DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 31 North America Biopharmaceutical Processing Market by Region, 2020 - 2023, USD Million
TABLE 32 North America Biopharmaceutical Processing Market by Region, 2024 - 2031, USD Million
TABLE 33 North America Others Market by Region, 2020 - 2023, USD Million
TABLE 34 North America Others Market by Region, 2024 - 2031, USD Million
TABLE 35 North America DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 36 North America DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 37 North America Oligonucleotide Synthesis Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Oligonucleotide Synthesis Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 41 North America DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 42 North America DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 43 North America mRNA Production Market by Country, 2020 - 2023, USD Million
TABLE 44 North America mRNA Production Market by Country, 2024 - 2031, USD Million
TABLE 45 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 46 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 47 North America DNases, Ligases, And RNA Polymerases Market by Country, 2020 - 2023, USD Million
TABLE 48 North America DNases, Ligases, And RNA Polymerases Market by Country, 2024 - 2031, USD Million
TABLE 49 US DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 50 US DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 51 US DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 52 US DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 53 US DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 54 US DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 55 US DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 56 US DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 57 Canada DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 58 Canada DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 59 Canada DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 60 Canada DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 61 Canada DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 62 Canada DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 63 Canada DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 64 Canada DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 65 Mexico DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 66 Mexico DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 67 Mexico DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 68 Mexico DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 69 Mexico DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 70 Mexico DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 71 Mexico DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 72 Mexico DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 73 Rest of North America DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 74 Rest of North America DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 75 Rest of North America DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 76 Rest of North America DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 77 Rest of North America DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 78 Rest of North America DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 79 Rest of North America DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 80 Rest of North America DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 81 Europe DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 82 Europe DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 83 Europe DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 84 Europe DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 85 Europe Biopharmaceutical Processing Market by Country, 2020 - 2023, USD Million
TABLE 86 Europe Biopharmaceutical Processing Market by Country, 2024 - 2031, USD Million
TABLE 87 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 88 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 89 Europe DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 90 Europe DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 91 Europe Oligonucleotide Synthesis Market by Country, 2020 - 2023, USD Million
TABLE 92 Europe Oligonucleotide Synthesis Market by Country, 2024 - 2031, USD Million
TABLE 93 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 94 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 95 Europe DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 96 Europe DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 97 Europe mRNA Production Market by Country, 2020 - 2023, USD Million
TABLE 98 Europe mRNA Production Market by Country, 2024 - 2031, USD Million
TABLE 99 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 100 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 101 Europe DNases, Ligases, And RNA Polymerases Market by Country, 2020 - 2023, USD Million
TABLE 102 Europe DNases, Ligases, And RNA Polymerases Market by Country, 2024 - 2031, USD Million
TABLE 103 Germany DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 104 Germany DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 105 Germany DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 106 Germany DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 107 Germany DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 108 Germany DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 109 Germany DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 110 Germany DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 111 UK DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 112 UK DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 113 UK DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 114 UK DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 115 UK DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 116 UK DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 117 UK DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 118 UK DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 119 France DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 120 France DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 121 France DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 122 France DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 123 France DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 124 France DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 125 France DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 126 France DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 127 Russia DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 128 Russia DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 129 Russia DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 130 Russia DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 131 Russia DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 132 Russia DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 133 Russia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 134 Russia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 135 Spain DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 136 Spain DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 137 Spain DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 138 Spain DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 139 Spain DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 140 Spain DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 141 Spain DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 142 Spain DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 143 Italy DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 144 Italy DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 145 Italy DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 146 Italy DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 147 Italy DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 148 Italy DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 149 Italy DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 150 Italy DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 151 Rest of Europe DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 152 Rest of Europe DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 153 Rest of Europe DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 154 Rest of Europe DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 155 Rest of Europe DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 156 Rest of Europe DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 157 Rest of Europe DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 158 Rest of Europe DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 159 Asia Pacific DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 160 Asia Pacific DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 161 Asia Pacific DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 162 Asia Pacific DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 163 Asia Pacific Biopharmaceutical Processing Market by Country, 2020 - 2023, USD Million
TABLE 164 Asia Pacific Biopharmaceutical Processing Market by Country, 2024 - 2031, USD Million
TABLE 165 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 166 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 167 Asia Pacific DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 168 Asia Pacific DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 169 Asia Pacific Oligonucleotide Synthesis Market by Country, 2020 - 2023, USD Million
TABLE 170 Asia Pacific Oligonucleotide Synthesis Market by Country, 2024 - 2031, USD Million
TABLE 171 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 172 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 173 Asia Pacific DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 174 Asia Pacific DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 175 Asia Pacific mRNA Production Market by Country, 2020 - 2023, USD Million
TABLE 176 Asia Pacific mRNA Production Market by Country, 2024 - 2031, USD Million
TABLE 177 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 178 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 179 Asia Pacific DNases, Ligases, And RNA Polymerases Market by Country, 2020 - 2023, USD Million
TABLE 180 Asia Pacific DNases, Ligases, And RNA Polymerases Market by Country, 2024 - 2031, USD Million
TABLE 181 China DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 182 China DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 183 China DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 184 China DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 185 China DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 186 China DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 187 China DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 188 China DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 189 Japan DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 190 Japan DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 191 Japan DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 192 Japan DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 193 Japan DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 194 Japan DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 195 Japan DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 196 Japan DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 197 India DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 198 India DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 199 India DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 200 India DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 201 India DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 202 India DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 203 India DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 204 India DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 205 South Korea DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 206 South Korea DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 207 South Korea DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 208 South Korea DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 209 South Korea DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 210 South Korea DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 211 South Korea DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 212 South Korea DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 213 Singapore DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 214 Singapore DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 215 Singapore DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 216 Singapore DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 217 Singapore DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 218 Singapore DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 219 Singapore DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 220 Singapore DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 221 Malaysia DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 222 Malaysia DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 223 Malaysia DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 224 Malaysia DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 225 Malaysia DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 226 Malaysia DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 227 Malaysia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 228 Malaysia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 229 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 230 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 231 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 232 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 233 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 234 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 235 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 236 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 237 LAMEA DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 238 LAMEA DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 239 LAMEA DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 240 LAMEA DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 241 LAMEA Biopharmaceutical Processing Market by Country, 2020 - 2023, USD Million
TABLE 242 LAMEA Biopharmaceutical Processing Market by Country, 2024 - 2031, USD Million
TABLE 243 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 244 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 245 LAMEA DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 246 LAMEA DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 247 LAMEA Oligonucleotide Synthesis Market by Country, 2020 - 2023, USD Million
TABLE 248 LAMEA Oligonucleotide Synthesis Market by Country, 2024 - 2031, USD Million
TABLE 249 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 250 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 251 LAMEA DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 252 LAMEA DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 253 LAMEA mRNA Production Market by Country, 2020 - 2023, USD Million
TABLE 254 LAMEA mRNA Production Market by Country, 2024 - 2031, USD Million
TABLE 255 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 256 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 257 LAMEA DNases, Ligases, And RNA Polymerases Market by Country, 2020 - 2023, USD Million
TABLE 258 LAMEA DNases, Ligases, And RNA Polymerases Market by Country, 2024 - 2031, USD Million
TABLE 259 Brazil DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 260 Brazil DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 261 Brazil DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 262 Brazil DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 263 Brazil DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 264 Brazil DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 265 Brazil DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 266 Brazil DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 267 Argentina DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 268 Argentina DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 269 Argentina DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 270 Argentina DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 271 Argentina DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 272 Argentina DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 273 Argentina DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 274 Argentina DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 275 UAE DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 276 UAE DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 277 UAE DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 278 UAE DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 279 UAE DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 280 UAE DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 281 UAE DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 282 UAE DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 283 Saudi Arabia DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 284 Saudi Arabia DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 285 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 286 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 287 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 288 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 289 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 290 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 291 South Africa DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 292 South Africa DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 293 South Africa DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 294 South Africa DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 295 South Africa DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 296 South Africa DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 297 South Africa DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 298 South Africa DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 299 Nigeria DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 300 Nigeria DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 301 Nigeria DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 302 Nigeria DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 303 Nigeria DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 304 Nigeria DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 305 Nigeria DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 306 Nigeria DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 307 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market, 2020 - 2023, USD Million
TABLE 308 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market, 2024 - 2031, USD Million
TABLE 309 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by DNases Application, 2020 - 2023, USD Million
TABLE 310 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by DNases Application, 2024 - 2031, USD Million
TABLE 311 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2020 - 2023, USD Million
TABLE 312 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by Ligases Application, 2024 - 2031, USD Million
TABLE 313 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2020 - 2023, USD Million
TABLE 314 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application, 2024 - 2031, USD Million
TABLE 315 Key Information - Thermo Fisher Scientific, Inc.
TABLE 316 key Information - Merck KGaA
TABLE 317 key Information - Agilent Technologies, Inc.
TABLE 318 key Information - Promega Corporation
TABLE 319 Key Information - RayBiotech Life, Inc.
TABLE 320 Key Information - Qiagen N.V.
TABLE 321 Key Information - Abnova Corporation
TABLE 322 Key Information - Takara Bio Inc.
TABLE 323 Key Information - BPS Bioscience, Inc.
TABLE 324 Key Information - New England BioLabs, Inc.

The Global DNases, Ligases, And RNA Polymerases Market size is expected to reach $1.6 billion by 2031, rising at a market growth of 10.4% CAGR during the forecast period.

North America is home to some of the world's leading biotechnology and pharmaceutical companies, particularly the United States. Thus, the North America region acquired $273.68 million revenue in 2023. Increased use of DNases, Ligases, And RNA Polymerases results from this financial support. These enzymes are necessary for various molecular biology and genetic engineering applications. Specific grants and subsidies targeted at innovative pharmaceutical research bolster the demand for these enzymes as they are critical tools in developing new drugs and therapies.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In 2022, February, QIAGEN formed a partnership with Singular Genomics Systems to verify its QIAseq kits, a product line for both RNA and DNA sample prep, with the G4 analysis platform. Additionally, In 2021, August, QIAGEN came into a partnership with GT Molecular to deliver a comprehensive wastewater workflow solution developed to allow management of COVID-19 outbreaks by U.S. and Canadian laboratories, with forthcoming opportunities to deliver the solution in other countries.

Based on the Analysis presented in the KBV Cardinal matrix; Thermo Fisher Scientific, Inc. is the forerunner in the DNases, Ligases, And RNA Polymerases Market. In February 2022, Thermo Fisher Scientific joined hands with Moderna, a biotechnology company developing messenger RNA. Under this collaboration, the companies aimed to allow reliable large-scale manufacturing in the U.S. of Spikevax, Moderna's COVID-19 vaccine, and other investigational mRNA drugs in its channel. Companies such as Merck KGaA, Agilent Technologies, Inc., Qiagen N.V are some of the key innovators in DNases, Ligases, And RNA Polymerases Market.

COVID-19 Impact Analysis

In the early stages of the pandemic, disruptions to global supply chains, logistics, and manufacturing operations affected the availability of DNases, Ligases, RNA Polymerases, and other molecular biology reagents. Border closures, travel restrictions, and lockdown measures impeded the movement of goods, leading to product shipment and distribution delays. The COVID-19 pandemic disrupted research and development activities in academic institutions, biotechnology companies, and pharmaceutical firms, affecting experimental timelines and project progress. Thus, the Impact of the COVID-19 pandemic had a moderate impact on the market.

Market Growth Factors

Genomic research involves the study of DNA and RNA sequences to understand genetic variations, gene expression patterns, and molecular mechanisms underlying biological processes. DNases, Ligases, And RNA Polymerases are essential enzymes used in nucleic acid manipulation techniques such as sequencing, PCR amplification, cloning, and gene expression analysis, driving market demand. Hence, the expansion of genomic research is driving the market's growth.

The biotechnology and pharmaceutical industries rely heavily on DNases, Ligases, And RNA Polymerases for various applications in biopharmaceutical development. These enzymes are essential for molecular cloning, gene expression, protein production, and recombinant DNA technology used in biologics production, such as therapeutic proteins, monoclonal antibodies, and gene therapies. Thus, the biotechnology and pharmaceutical industries are propelling the market's growth.

Market Restraining Factors

Enzyme production involves complex manufacturing processes, including fermentation, purification, and formulation, which require specialized equipment, facilities, and expertise. These processes are resource-intensive and require substantial investments in infrastructure, technology, and skilled personnel, contributing to high production costs. Therefore, the high enzyme production costs are propelling the market's growth.

DNases Application Outlook

Based on DNases application, the market is divided into biopharmaceutical processing and others. The others segment witnessed a 23% revenue share in the market in 2023. DNases are utilized in environmental biotechnology to degrade DNA contaminants in soil and water, aiding in the bioremediation of polluted environments. DNases are also used in the food industry to remove DNA from food products, such as dairy and meat, to prevent spoilage and improve shelf life.

Ligases Application Outlook

On the basis of Ligases application, the market is segmented into oligonucleotide synthesis and other. In 2023, the other segments attained a 56% revenue share in the market. Ligases join DNA fragments, such as vectors, during molecular cloning and subcloning procedures and insert DNA. They facilitate the assembly of synthetic genes by ligating oligonucleotide fragments into longer DNA sequences.

RNA Polymerases Application Outlook

By RNA polymerases application, the market is divided into mRNA production and others. The others segment procured a remarkable revenue share in the market in 2023. RNA polymerases are utilized in IVT reactions to produce RNA transcripts from DNA templates in vitro. These synthetic RNA molecules serve as valuable tools in molecular biology research, enabling the generation of RNA probes, standards, controls, and expression vectors for various applications.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated a substantial 28% revenue share in the market. The Asia Pacific region is home to large-scale genomic research initiatives to understand genetic variations, disease mechanisms, and population genetics. DNases, Ligases, And RNA Polymerases play crucial roles in genomic research, including DNA sequencing, gene expression analysis, and genome editing, driving demand for enzyme products in academic and research institutions across the region.

Recent Strategies Deployed in the Market

Jan-2023: Agilent Technologies Inc. took over Avida Biomed, an early-stage life sciences company developing high-performance target enrichment workflows with unique capabilities. This acquisition would complement company's market-leading SureSelect portfolio and further augment Agilent's strategy to expand into the high-growth clinical research and diagnostics markets.
Feb-2022: Thermo Fisher Scientific joined hands with Moderna, a biotechnology company developing messenger RNA. Under this collaboration, the companies aimed to allow reliable large-scale manufacturing in the U.S. of Spikevax, Moderna's COVID-19 vaccine, and other investigational mRNA drugs in its channel.
Feb-2022: Merck KGaA came into a partnership with eTheRNA, a science and technology organization. Together the companies would target messenger RNA therapeutics using eTheRNA's mRNA and lipid nanoparticle technologies in multiple model methods. Additionally, mRNA encoding antigens would be selected by Merck KGaA as suitable for human diseases. Moreover, eTheRNA acquires immunotherapies that target the essential role of dendritic cells in the human immune system.
Feb-2022: Merck completed the acquisition of Exelead, a biopharmaceutical contract development, and manufacturing business. Through this acquisition, Exelead's leading abilities, and highly experienced crew, Merck acquires a crucial landmark in evolving one of the supreme CDMO players in mRNA vaccines and therapeutics, delivering a combined CDMO across the mRNA value chain from pre-clinical to retail.
Feb-2022: QIAGEN formed a partnership with Singular Genomics Systems, a company leveraging novel next-generation sequencing. With this partnership, QIAGEN aimed to verify its QIAseq kits, a product line for both RNA and DNA sample prep, with the G4 analysis platform. Additionally, this partnership would highlight QIAGEN's dedication to delivering a plug-and-play solution for consumers to combine the G4 into living NGS workflows.

List of Key Companies Profiled

Thermo Fisher Scientific, Inc.
Merck KGaA
Agilent Technologies, Inc.
Promega Corporation
Raybiotech Life, Inc.
Qiagen N.V
Abnova Corporation
Takara Bio Inc. (Takara Holdings Inc.)
BPS Bioscience, Inc.
New England Biolabs, Inc.

Global DNases, Ligases, And RNA Polymerases Market Report Segmentation

By DNases Application

Biopharmaceutical Processing
Others

By Ligases Application

Oligonucleotide Synthesis
Others

By RNA Polymerases Application

mRNA Production
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global DNases, Ligases, And RNA Polymerases Market, by DNases Application
- 1.4.2 Global DNases, Ligases, And RNA Polymerases Market, by Ligases Application
- 1.4.3 Global DNases, Ligases, And RNA Polymerases Market, by RNA Polymerases Application
- 1.4.4 Global DNases, Ligases, And RNA Polymerases Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.2.4 Geographical Expansions
4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4 Porter Five Forces Analysis

Chapter 5. Global DNases, Ligases, And RNA Polymerases Market by DNases Application

5.1 Global Biopharmaceutical Processing Market by Region
5.2 Global Others Market by Region

Chapter 6. Global DNases, Ligases, And RNA Polymerases Market by Ligases Application

6.1 Global Oligonucleotide Synthesis Market by Region
6.2 Global Others Market by Region

Chapter 7. Global DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application

7.1 Global mRNA Production Market by Region
7.2 Global Others Market by Region

Chapter 8. Global DNases, Ligases, And RNA Polymerases Market by Region

8.1 North America DNases, Ligases, And RNA Polymerases Market
- 8.1.1 North America DNases, Ligases, And RNA Polymerases Market by DNases Application
  - 8.1.1.1 North America Biopharmaceutical Processing Market by Region
  - 8.1.1.2 North America Others Market by Region
- 8.1.2 North America DNases, Ligases, And RNA Polymerases Market by Ligases Application
  - 8.1.2.1 North America Oligonucleotide Synthesis Market by Country
  - 8.1.2.2 North America Others Market by Country
- 8.1.3 North America DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.1.3.1 North America mRNA Production Market by Country
  - 8.1.3.2 North America Others Market by Country
- 8.1.4 North America DNases, Ligases, And RNA Polymerases Market by Country
  - 8.1.4.1 US DNases, Ligases, And RNA Polymerases Market
    - 8.1.4.1.1 US DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.1.4.1.2 US DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.1.4.1.3 US DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.1.4.2 Canada DNases, Ligases, And RNA Polymerases Market
    - 8.1.4.2.1 Canada DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.1.4.2.2 Canada DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.1.4.2.3 Canada DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.1.4.3 Mexico DNases, Ligases, And RNA Polymerases Market
    - 8.1.4.3.1 Mexico DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.1.4.3.2 Mexico DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.1.4.3.3 Mexico DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.1.4.4 Rest of North America DNases, Ligases, And RNA Polymerases Market
    - 8.1.4.4.1 Rest of North America DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.1.4.4.2 Rest of North America DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.1.4.4.3 Rest of North America DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
8.2 Europe DNases, Ligases, And RNA Polymerases Market
- 8.2.1 Europe DNases, Ligases, And RNA Polymerases Market by DNases Application
  - 8.2.1.1 Europe Biopharmaceutical Processing Market by Country
  - 8.2.1.2 Europe Others Market by Country
- 8.2.2 Europe DNases, Ligases, And RNA Polymerases Market by Ligases Application
  - 8.2.2.1 Europe Oligonucleotide Synthesis Market by Country
  - 8.2.2.2 Europe Others Market by Country
- 8.2.3 Europe DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.2.3.1 Europe mRNA Production Market by Country
  - 8.2.3.2 Europe Others Market by Country
- 8.2.4 Europe DNases, Ligases, And RNA Polymerases Market by Country
  - 8.2.4.1 Germany DNases, Ligases, And RNA Polymerases Market
    - 8.2.4.1.1 Germany DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.2.4.1.2 Germany DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.2.4.1.3 Germany DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.2.4.2 UK DNases, Ligases, And RNA Polymerases Market
    - 8.2.4.2.1 UK DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.2.4.2.2 UK DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.2.4.2.3 UK DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.2.4.3 France DNases, Ligases, And RNA Polymerases Market
    - 8.2.4.3.1 France DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.2.4.3.2 France DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.2.4.3.3 France DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.2.4.4 Russia DNases, Ligases, And RNA Polymerases Market
    - 8.2.4.4.1 Russia DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.2.4.4.2 Russia DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.2.4.4.3 Russia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.2.4.5 Spain DNases, Ligases, And RNA Polymerases Market
    - 8.2.4.5.1 Spain DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.2.4.5.2 Spain DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.2.4.5.3 Spain DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.2.4.6 Italy DNases, Ligases, And RNA Polymerases Market
    - 8.2.4.6.1 Italy DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.2.4.6.2 Italy DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.2.4.6.3 Italy DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.2.4.7 Rest of Europe DNases, Ligases, And RNA Polymerases Market
    - 8.2.4.7.1 Rest of Europe DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.2.4.7.2 Rest of Europe DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.2.4.7.3 Rest of Europe DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
8.3 Asia Pacific DNases, Ligases, And RNA Polymerases Market
- 8.3.1 Asia Pacific DNases, Ligases, And RNA Polymerases Market by DNases Application
  - 8.3.1.1 Asia Pacific Biopharmaceutical Processing Market by Country
  - 8.3.1.2 Asia Pacific Others Market by Country
- 8.3.2 Asia Pacific DNases, Ligases, And RNA Polymerases Market by Ligases Application
  - 8.3.2.1 Asia Pacific Oligonucleotide Synthesis Market by Country
  - 8.3.2.2 Asia Pacific Others Market by Country
- 8.3.3 Asia Pacific DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.3.3.1 Asia Pacific mRNA Production Market by Country
  - 8.3.3.2 Asia Pacific Others Market by Country
- 8.3.4 Asia Pacific DNases, Ligases, And RNA Polymerases Market by Country
  - 8.3.4.1 China DNases, Ligases, And RNA Polymerases Market
    - 8.3.4.1.1 China DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.3.4.1.2 China DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.3.4.1.3 China DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.3.4.2 Japan DNases, Ligases, And RNA Polymerases Market
    - 8.3.4.2.1 Japan DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.3.4.2.2 Japan DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.3.4.2.3 Japan DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.3.4.3 India DNases, Ligases, And RNA Polymerases Market
    - 8.3.4.3.1 India DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.3.4.3.2 India DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.3.4.3.3 India DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.3.4.4 South Korea DNases, Ligases, And RNA Polymerases Market
    - 8.3.4.4.1 South Korea DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.3.4.4.2 South Korea DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.3.4.4.3 South Korea DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.3.4.5 Singapore DNases, Ligases, And RNA Polymerases Market
    - 8.3.4.5.1 Singapore DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.3.4.5.2 Singapore DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.3.4.5.3 Singapore DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.3.4.6 Malaysia DNases, Ligases, And RNA Polymerases Market
    - 8.3.4.6.1 Malaysia DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.3.4.6.2 Malaysia DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.3.4.6.3 Malaysia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.3.4.7 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market
    - 8.3.4.7.1 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.3.4.7.2 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.3.4.7.3 Rest of Asia Pacific DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
8.4 LAMEA DNases, Ligases, And RNA Polymerases Market
- 8.4.1 LAMEA DNases, Ligases, And RNA Polymerases Market by DNases Application
  - 8.4.1.1 LAMEA Biopharmaceutical Processing Market by Country
  - 8.4.1.2 LAMEA Others Market by Country
- 8.4.2 LAMEA DNases, Ligases, And RNA Polymerases Market by Ligases Application
  - 8.4.2.1 LAMEA Oligonucleotide Synthesis Market by Country
  - 8.4.2.2 LAMEA Others Market by Country
- 8.4.3 LAMEA DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.4.3.1 LAMEA mRNA Production Market by Country
  - 8.4.3.2 LAMEA Others Market by Country
- 8.4.4 LAMEA DNases, Ligases, And RNA Polymerases Market by Country
  - 8.4.4.1 Brazil DNases, Ligases, And RNA Polymerases Market
    - 8.4.4.1.1 Brazil DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.4.4.1.2 Brazil DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.4.4.1.3 Brazil DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.4.4.2 Argentina DNases, Ligases, And RNA Polymerases Market
    - 8.4.4.2.1 Argentina DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.4.4.2.2 Argentina DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.4.4.2.3 Argentina DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.4.4.3 UAE DNases, Ligases, And RNA Polymerases Market
    - 8.4.4.3.1 UAE DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.4.4.3.2 UAE DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.4.4.3.3 UAE DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.4.4.4 Saudi Arabia DNases, Ligases, And RNA Polymerases Market
    - 8.4.4.4.1 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.4.4.4.2 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.4.4.4.3 Saudi Arabia DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.4.4.5 South Africa DNases, Ligases, And RNA Polymerases Market
    - 8.4.4.5.1 South Africa DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.4.4.5.2 South Africa DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.4.4.5.3 South Africa DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.4.4.6 Nigeria DNases, Ligases, And RNA Polymerases Market
    - 8.4.4.6.1 Nigeria DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.4.4.6.2 Nigeria DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.4.4.6.3 Nigeria DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
  - 8.4.4.7 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market
    - 8.4.4.7.1 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by DNases Application
    - 8.4.4.7.2 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by Ligases Application
    - 8.4.4.7.3 Rest of LAMEA DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application

Chapter 9. Company Profiles

9.1 Thermo Fisher Scientific, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Partnerships, Collaborations, and Agreements:
  - 9.1.5.2 Product Launches and Product Expansions:
  - 9.1.5.3 Acquisition and Mergers:
- 9.1.6 SWOT Analysis
9.2 Merck KGaA
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Partnerships, Collaborations, and Agreements:
  - 9.2.5.2 Acquisition and Mergers:
- 9.2.6 SWOT Analysis
9.3 Agilent Technologies, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Acquisition and Mergers:
- 9.3.6 SWOT Analysis
9.4 Promega Corporation
- 9.4.1 Company Overview
- 9.4.2 Recent strategies and developments:
  - 9.4.2.1 Product Launches and Product Expansions:
  - 9.4.2.2 Geographical Expansions:
- 9.4.3 SWOT Analysis
9.5 RayBiotech Life, Inc.
- 9.5.1 Company Overview
- 9.5.2 SWOT Analysis
9.6 Qiagen N.V.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
  - 9.6.5.1 Partnerships, Collaborations, and Agreements:
  - 9.6.5.2 Product Launches and Product Expansions:
- 9.6.6 SWOT Analysis
9.7 Abnova Corporation
- 9.7.1 Company Overview
- 9.7.2 Recent strategies and developments:
  - 9.7.2.1 Partnerships, Collaborations, and Agreements:
- 9.7.3 SWOT Analysis
9.8 Takara Bio Inc. (Takara Holdings Inc.)
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
9.9 BPS Bioscience, Inc.
- 9.9.1 Company Overview
9.10. New England Biolabs, Inc.
- 9.10.1 Company Overview
- 9.10.2 SWOT Analysis

DNase、リガーゼ、RNAポリメラーゼの世界市場：規模、シェア、動向分析レポート（DNaseアプリケーション別、リガーゼアプリケーション別、RNAポリメラーゼアプリケーション別、地域別展望と予測、2024-2031年）

Global DNases, Ligases, and RNA Polymerases Market Size, Share & Trends Analysis Report By DNases Application, By Ligases Application (Oligonucleotide Synthesis and Others), By RNA Polymerases Application, By Regional Outlook and Forecast, 2024 - 2031

目次

第1章市場範囲と調査手法

第2章市場要覧

第3章市場概要

第4章競合分析- 世界

第5章世界市場： DNases用途別

第6章世界市場：リガーゼの用途別

第7章世界の市場RNAポリメラーゼの応用

第8章世界市場：地域別

第9章企業プロファイル

第10章 DNase、リガーゼ、RNAポリメラーゼ市場の成功必須条件

LIST OF TABLES

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Competition Analysis - Global

Chapter 5. Global DNases, Ligases, And RNA Polymerases Market by DNases Application

Chapter 6. Global DNases, Ligases, And RNA Polymerases Market by Ligases Application

Chapter 7. Global DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application

Chapter 8. Global DNases, Ligases, And RNA Polymerases Market by Region

Chapter 9. Company Profiles

Chapter 10. Winning Imperatives of DNases, Ligases, And RNA Polymerases Market

DNase、リガーゼ、RNAポリメラーゼの世界市場：規模、シェア、動向分析レポート （DNaseアプリケーション別、リガーゼアプリケーション別、RNAポリメラーゼアプリケーション別、地域別展望と予測、2024-2031年）

Global DNases, Ligases, and RNA Polymerases Market Size, Share & Trends Analysis Report By DNases Application, By Ligases Application (Oligonucleotide Synthesis and Others), By RNA Polymerases Application, By Regional Outlook and Forecast, 2024 - 2031

目次

第1章 市場範囲と調査手法

第2章 市場要覧

第3章 市場概要

第4章 競合分析- 世界

第5章 世界市場： DNases用途別

第6章 世界市場：リガーゼの用途別

第7章 世界の市場RNAポリメラーゼの応用

第8章 世界市場：地域別

第9章 企業プロファイル

第10章 DNase、リガーゼ、RNAポリメラーゼ市場の成功必須条件

LIST OF TABLES

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Competition Analysis - Global

Chapter 5. Global DNases, Ligases, And RNA Polymerases Market by DNases Application

Chapter 6. Global DNases, Ligases, And RNA Polymerases Market by Ligases Application

Chapter 7. Global DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application

Chapter 8. Global DNases, Ligases, And RNA Polymerases Market by Region

Chapter 9. Company Profiles

Chapter 10. Winning Imperatives of DNases, Ligases, And RNA Polymerases Market

DNase、リガーゼ、RNAポリメラーゼの世界市場：規模、シェア、動向分析レポート（DNaseアプリケーション別、リガーゼアプリケーション別、RNAポリメラーゼアプリケーション別、地域別展望と予測、2024-2031年）

第1章市場範囲と調査手法

第2章市場要覧

第3章市場概要

第4章競合分析- 世界

第5章世界市場： DNases用途別

第6章世界市場：リガーゼの用途別

第7章世界の市場RNAポリメラーゼの応用

第8章世界市場：地域別

第9章企業プロファイル